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Pre to Post Flight Papilledema 
(First case 2005. N=6)  
Pre Flight 
Fundoscopic images of 
the right and left optic 
disc.  
Post Flight 
Fundoscopic images of 
the right and left optic 
disc showing Grade 3 
edema right and Grade 
1 edema left .   
Pre Flight 
OD 
Post Flight 
OD 
OS 
OS 
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Visual Impairment Intracranial Pressure  
Syndrome Signs 
MRI Orbital 
Image 
showing 
globe 
flattening  
Normal Globe Flatten Globe 
•Choroidal Folds 
- parallel grooves in 
the posterior pole 
•Globe Flattening  
•Optic Disc Edema (swelling)  
•Altered Blood flow 
•“cotton wool” spots  
•Hyperopic Shifts 
-Up to +1.75 diopters  
•Increased Optic Nerve 
Sheath Diameter 
3 
ICP 
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How do these clinical signs fit together? 
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Cephalad Fluid Shift 
5 
       1G          0G 
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Initial Identification of the VIIP: 
Subjective Changes in Vision 
• 50% of long-duration (ISS) astronauts report a 
subjective degradation in vision, primarily increasing 
farsightedness 
• Hyperopic shift 
 Decreased near visual acuity, distant vision intact 
Hyperopic Eye 
Normal Eye 
(1 mm decrease in axial length is equivalent to a 3 diopter hyperopic shift)  
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*Infectious 
Meningitis (bacterial or viral) 
Lyme disease  
HIV 
Poliomyelitis  
Coxsackie B encephalitis 
Guillain-Barre syndrome  
Infectious mononucleosis 
Syphilis 
Malaria 
*Metabolic/endocrine 
Lupus 
Sarcoidosis 
Hypoparathyroidism 
Addison’s disease 
*Drugs 
Tetracycline 
Minocycline  
Isotretinoin (Accutane)  
 All-trans retinoic acid 
Excessive ingestion of 
Vitamin A 
Amiodarone 
Nitofurantoin  
Lithium  
Levonorgestral (Norplant) 
Growth hormone treatments 
Steroid withdrawal 
Causes of Globe Flattening 
*Structural 
Intracranial Hypertension 
IIH 
Head Trauma 
Tumors 
Orbital mass 
retrobulbar tumours 
*Vascular 
Subarachnoid hemorrhage 
Sinus thrombosus 
*Inflammatory 
Long-standing orbital 
inflammation 
Uveitis 
Disciform degeneration 
Posterior scleritis 
* Raised Intracranial Pressure 
√ 
X 
X 
X 
X 
X 
X 
X 
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Choroidal Folds 
Postflight 
OD             OS 
 
Postflight 
OD                
 
 
Preflight                   Postflight 
Inferior            Superior      Inferior                       Superior 
  
Thickening of the 
choroid secondary 
to venous blood 
engorgement from 
uG fluid shift 
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Causes of Choroidal Folds 
 Choroidal folds are folds of the posterior pole, at the level of the choroid 
 
 Structural 
Exophthalmos 
High hyperopia 
Ocular hypotony 
Posteriorly located choroidal 
detachment 
Primary retinal detachment 
Postoperative condition (scleral 
buckle) 
Tumors 
Choroidal tumor, such as a 
melanoma 
Orbital mass 
retrobulbar tumours 
Massive cranioorbital 
hemangiopericytoma 
Vascular 
Subretinal neovascularization 
Inflammatory 
Long-standing orbital inflammation 
Uveitis 
Disciform degeneration 
posterior scleritis 
Infectious 
Infection of paranasal sinuses 
Metabolic/endocrine 
Graves disease (Basedow 
syndrome) 
Idiopathic 
Increased ICP 
Papilledema 
intracranial hypertension 
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Venous Congestion & Elevated ICP: 
Transmitted to the Choroid? 
MRI Brain Venogram 
P Venous Sinus 
P  
P  
Transmitted via the 
ophthalmic veins 
 Ansari et al. 2003. Measurement of Choroidal blood flow in Zero Gravity KC135 
parabolic flight experiment.  
• Choroidal volume and flow increase significantly in low G environment when 
compared with the baseline data (1G): 75% increase for volume, and 105% for flow. 
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Column1
IOP for Five Shuttle Missions (10 Subjects) 
Pre-flight, In-flight-Post-flight 
IO
P 
m
m
Hg
 
Ocular Hypotension 
Ocular Hypertension 
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Raised Intracranial Pressure-
Qualitative Measurement with ONSD 
 
12 
Elevated ICP 
transmitted to 
optic nerve 
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In Flight B-scan Ultrasound 
Shalizan Sharipov & Leroy Chiao 
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ISS In-Flight ONSD for VIIP Cases & Non-Cases 
Plotted Against Ground Study of ONSD & ICP  
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Pre to Post Flight Papilledema 
(First case 2005. N=6)  
Pre Flight 
Fundoscopic images of 
the right and left optic 
disc.  
Post Flight 
Fundoscopic images of 
the right and left optic 
disc showing Grade 3 
edema right and Grade 
1 edema left .   
Pre Flight 
OD 
Post Flight 
OD 
OS 
OS 
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√ 
√ 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
X 
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Papilledema Mechanism 
1a central retinal artery in optic nerve 
1b central retinal artery in optic disc 
2 short ciliary arteries 
3 plial arterioles 
4 arterioles from choroid layer 
5 Central retinal vein 
a subarachnioid space 
d dura 
D optic disc 
N optic nerve 
V vitreous 
X compromised perfusion 
Normal Papilledema 
Jinkins et al. 1987 
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ICP Related Disc Edema (Papilledema) 
Pathophysiology 
, 2007 
√ 
√ 
√ 
√ √ 
√ 
? 
? ? 
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VIIP Ocular Findings in ISS Astronauts 
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Partially Empty Sella (Turcica) 
Normal Pituitary 
Pituitary compressed by CSF 
“Partially empty sella” 
CSF 
CSF 
↑ICP 
Documented in 5 crew members 
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Current U.S. ISS VIIP Incidence: 
 45 U.S. ISS astronauts : 
– Unclassified astronauts N=16 (No MRI, OCT or ocular US)  
– Known Non-cases: N=8 
– Confirmed cases: N= 21 
 
– Class One:    N=2 
– Class Two:    N=13 
– Class Three: N=2 
– Class Four :  N=4 
 
 
 
 
71.2 % Class 1&2 
28.6 % Class 3&4 
Current VIIP Incidence as a % of U.S. ISS astronauts tested= 72.4%  
Increasing 
severity 
Clinical Classification: 
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 Class 1 ≥ .50 diopter cycloplegic refractive change and/or cotton wool spot  
  
 
22 
VIIP Clinical Practice Guideline  
Case Definition 
Class 2 ≥ .50 diopter cycloplegic refractive changes or cotton wool spot 
• Choroidal folds and/or optic nerve sheath distension and/or globe flattening 
and/or scotoma 
 
Class 3  ≥ .50 diopter cycloplegic refractive changes and/or cotton wool spot 
• Optic nerve sheath distension, and/or globe flattening and/or choroidal 
folds and/or scotoma 
• Papilledema of Grade 0-2.  
 
Class 4 ≥ .50 diopter cycloplegic refractive changes and/or cotton wool spot 
• Optic nerve sheath distension, and/or globe flattening and/or choroidal 
folds and/or scotoma 
• Papilledema Grade 2 or above. 
• Presenting symptoms of new headache, pulsatile tinnitus and/or 
transient visual obscurations 
• CSF opening pressure >25 cm H2O 
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VIIP Clinical Findings 
• To date 21 U.S. ISS long-duration spaceflight astronauts 
have developed some or all of the following findings:  
 
• Hyperopic shift  
• Cotton wool spots  
• Choroidal folds  
• Optic Nerve Sheath Distention 
• Globe flattening  
• Edema of the Optic disc (papilledema) 
• Partially empty sella 
 
 
 
 
 
 
Eye  
Findings 
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VIIP Clinical Findings 
• To date 21 U.S. ISS long-duration spaceflight astronauts 
have developed some or all of the following findings:  
 
• Hyperopic shift  
• Cotton wool spots  
• Choroidal folds  
• Optic Nerve Sheath Distention 
• Globe flattening  
• Edema of the Optic disc (papilledema) 
• Partially Empty Sella  
 
 
 
 
 
 
Signs of elevated 
intracranial pressure 
Eye  
Findings 
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NASA ISS Astronaut LPs to Date  
 LPs conducted if clinically indicated 
 5 LPs postflight in crewmembers with optic disc edema, no preflight LP 
as baseline 
 Results: Mild to moderate elevation in ICP, normal composition 
 Postflight measure is inadequate surrogate to in-flight measurement of 
ICP (cephalad fluid shift & CO2 challenge absent) 
 
 
Case 
Opening pressure (cm 
H2O)  
Normal range 10-20 cm H2O  
Opening pressure 
(mmHg)  
Normal range 5-15 mm H2O  
 
Time after flight 
(days) 
A 22 16.2 66 
B 21 15.4 19 
C 28 20.6 12 
D 28.5 21.0 57 
E 18 13.2 8 
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1. Symptoms of raised intracranial pressure (headache, nausea, vomiting,      
transient visual obscurations, or papilledema) 
2 No localizing signs with the exception of abducens (sixth) nerve palsy 
3 The patient is awake and alert 
4 Normal CT/MRI findings without evidence of thrombosis/tumor 
5 LP opening pressure of >20 cmH2O (non obese) and normal CSF composition 
6 No other explanation for the raised intracranial pressure 
Idiopathic Intracranial Hypertension 
Diagnostic Criteria: 
Modified Dandy Criteria 
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Mimics of IIH 
↑CVP/ICP 
Maybe VIIP is not IIH? 
However, the pathophysiology 
may be closely related re: 
CVP & ICP 
↑ICP 
↑ICP/CVP 
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 Finding Present in IH Present in IIH Present in VIIP 
Elevated ICP √ (>15mmHg) √ (>15mmHg) √*(15-21mmHg) 
Normal CSF X √ √ 
Papilledema 
 √ √ √ 
Flattening of 
Posterior Globes 
√  
64%/78% 
 
√ 
54/100 
43/-- 
80/-- 
63/-- 
 
√ 
Optic Nerve 
Protrusion 
√ 
 33%/100% 
 
√ 
37/100 
3/-- 
30/-- 
√ 
Partially Empty Sella √  56%/97% 
√ 
65/95 
53/-- 
80/-- 
70/ 
 
√ 
Optic Nerve Sheath 
Distension 
 
√  
92%/89% 
 
√ 
49/88 
67/-- 
45/-- 
√ 
Optic Nerve 
Tortuosity √ 
√ 
35/86 
40/-- 
40/-- 
√ 
Optic Nerve 
Enhancement -- 
√ 
4.3/100 
7/-- 
50/-- 
 
√ 
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 Finding Present in IH Present in IIH Present in VIIP 
Elevated ICP √ (>15mmHg) √ (>15mmHg) √*(15-21mmHg) 
Normal CSF X √ √ 
Papilledema 
 √ √ √ 
Flattening of 
Posterior Globes 
√ 64%/78% 
 
√ 
54%/100% 
43%/-- 
80%/-- 
63%/-- 
 
√ 
Optic Nerve 
Protrusion 
√ 33%/100% 
 
√ 
37/100 
3%/-- 
30%/-- 
√ 
Partially Empty Sella √ 56%/97%  
√ 
65/95 
53%/-- 
80%/-- 
70%/ 
 
√ 
Optic Nerve Sheath 
Distension 
√ 92%/89% 
 
 
√ 
49%/88% 
67%/-- 
45%/-- 
√ 
Optic Nerve 
Tortuosity 
√ 
 
√ 
35%/86% 
40%/-- 
40%/-- 
√ 
Optic Nerve 
Enhancement -- 
√ 
4.3%/100% 
7%/-- 
50%/-- 
 
√ 
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There is a rational hypothesis for the 
physiology. 
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Dose Response for the VIIP? Shuttle vs ISS 
 
 Kramer et. al. Orbital and Intracranial Effects of Microgravity: Findings at 3-T 
MR Imaging. Radiology: Vol 263:3 2012  
 N=27 Astronauts 
 Consistently higher percentage of findings for group with greater microgravity 
exposure, and increased severity of findings. 
Cumulative Lifetime Exposure to Microgravity Relative to Imaging Findings 
Time in 
UG  
No. 
Subjects 
Globe 
Flattening 
Optic 
Nerve 
Sheath 
Kinking 
ONSD>5.
9mm 
Optic Disc 
Protrusion 
Moderate 
or Greater 
Pituitary 
Concavity 
 
Papilledema 
<30d 
(Short) 
12 1 1 5 0 0 0 
>30d 
(Long) 
15 6 3 9 4 3 3 
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Cardiovascular CNS  Ocular 
+ + 
Primary Systems Involved 
Visual Impairment and Elevated Intracranial 
Pressure in Spaceflight 
Page No. 33 
Loss of Hydrostatic Drainage & 
Cerebral Venous Congestion 
Adapted from Rowell, 1988 
X 
Loss of  
 Hydrostatic Drainage 
9.8m/s2 
1G 0G 
C
EPH
ALA
D
 FLU
ID
 SH
IFT 
1G Supine 
Adapted from Hargens & Richardson, Respiratory Physiology & Neurobiology. 2009 
Page No. 34 
1 
2 
Elevated ICP in Simulated Microgravity 
 ICP measured during 4.5s free drop (N=5) 
 ICP increased 52%,  4.8 to 7.3 mmHg 
 Jugular bulb pressure ↑ 325% (N=7) i.e. loss of hydrostatic assisted venous 
drainage 
 Factors that may further raise ICP: Complete cephalad fluid shift, lymphatic 
congestion, Increased CO2  
 
 
0 3 4 1 -4 2 -1 -2 -3 
4.8mmHg 
7.3mmHg 
2. GOTOH et al. Cerebral Circulation during Acute Microgravity Induced by Free Drop in Anesthetized Rats Japanese Journal of Physiology, 53, 223–228, 2003 
0.4 mmHg 
1.7 mmHg 
1. Gotoh et al. Acute hemodynamic responses in the head during microgravity induced by free drop in anesthetized rats. Am J Physiology-Regulatory Integrative & Comparative Physiology. 2004 
Page No. 35 
CVP & ICP Increases with Acute 
Cephalad Fluid Shift 
Mavrocordatos et al. Effects of Neck Position and Head Elevation on Intracranial Pressure in Anaesthetized 
Neurosurgical Patients: Preliminary Results. J. Neurological Anesthesia. 2000 Jan;12(1):10-4. 
Effect of Head Tilt on ICP & CVP (N=15, Xage=58) 
ICP: 13.3mmHg +/- 2.9 
(CVP: 8.4mmHg +/-2.4)  
ICP: 7.0mmHg +/- 3.3 
(CVP: 2.9mmHg +/-2.1) 
ICP: 8.8mmHg +/- 3.3 
(CVP:3.9mmHg +/-2.3) 
ICP mmHg 
Increased CVP impedes cerebral venous drainage  
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Vascular Capacitance: 
Venous & Arterial 
20%=1L 
70-80%=4L 
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Venous Compliance 
Vein 
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Factors Increasing Venous Tone will Increase 
Cerebral Venous Outflow Resistance 
 Resting Tone of Venous Vessels 
Influenced by: 
• SNS tone↑ 
Resting Blood Pressure 
• Endothelin↑ 
• Nitric oxide↓ 
• Inflammatory cytokines ↑ 
 
(CVP) 
Although effects 
of tone less on 
venous side vs 
arterial, volume 
is much greater 
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Decreased Venous Compliance and Elevated  
CVP in Hypertensives 
 Normal CVP=2-6mmHg 
 A change in CVP determined by: 
change in volume (ΔV) of blood within 
the thoracic veins divided by the 
compliance of those veins:  
  ΔCVP = ΔV / Cv 
 CVP, measured in patients with 
essential hypertension is modestly 
increased, even with normal pumping 
ability of the heart 
 Decreased venous compliance 
contributes to the increase in CVP in 
hypertensive patients 
 
• Olivari et al. Pulmonary hemodynamics and right ventricular function in 
hypertension. Circulation 1978;57:1185-1190 
• Safar et al. Venous system in essential hypertension. Clin Science 
1985 Nov;69(5):497-504. 
• London et al. Hemodynamic effects of head-down tilt in normal 
subjects and sustained hypertensive patients Am J Physiol Heart Circ 
Physiol August 1, 1983 245:(2) H194-H202 
 
LV Hypertrophy 
LV Strain 
3mmHg 
6mmHg 
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CVP in Normotensives vs Hypertensives 
During 10o HDT 
 A decrease in venous vascular 
resistance among normotensives, 
due to inhibition of vasoconstrictor 
tone (-SNS +PNS), led to partial 
relief of the congestion; 
minimizing the impact of blood 
volume redistribution. 
 Hypertensives did not 
demonstrate a decrease in 
venous tone 
• The absence of this buffering 
effect of the veins in 
hypertensives may be 
contributing to the higher CVP 
and CO. 
N=9 
N=7 
London et al. 1983. Hemodynamic effects of head-down tilt in normal subjects and sustained hypertensive patients. Am J Physiol. 
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VIIP CPG Class & Blood Pressure  
CPG 
Classification N 
Mean  
Systolic BP 
Mean 
Diastolic BP 
3-4 5 130.1* P<0.001 82.3*P<0.05 
1-2 10 117.3 76.8 
0 5 118.1 76.7 
Resting blood pressure averaged over 3-4 annual exams, preflight ISS  
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Vascular Compliance in Astronauts following Short 
& Long Duration Missions- Estimated by Pulse 
Pressure and Stroke Volume During  Tilt Testing. 
Preflight Postflight 
Sh
or
t D
ur
at
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n 
Lo
ng
 D
ur
at
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n 
S
tro
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 V
ol
um
e 
(m
L)
 
S
tro
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 V
ol
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e 
(m
L)
 
Arterial Pulse Pressure (mmHg) 
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Cardiovascular Impacts to Cerebral 
Autoregulation 
S. Tzeng 
compliance √ 
√ 
√ 
√ 
√? 
√? 
√ 
√ 
Page No. 44 
Key Brain Areas Affected by Fluid Shift 
CSF Production 
CSF Resorbtion 
(AG-Venous) 
Venous 
Congestion 
Interstitial fluid 
Decreased CSF 
Displacement 
(Compliance Effect) 
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The Glymphatic Pathway: A Paravascular Pathway 
Facilitating CSF Flow through the Brain Parenchyma and 
the Clearance of Interstitial Solutes, Including Amyloid b 
 
 CSF enters the brain along para-
arterial routes,  ISF is cleared from the 
brain along paravenous routes.  
 Convective bulk ISF flow between 
these influx and clearance routes is 
facilitated by AQP4-dependent 
astroglial water flux and drives the 
clearance of interstitial solutes and 
fluid from the brain parenchyma.  
 Solutes and fluid may be 1. dispersed 
into the subarachnoid CSF, 2. enter 
the bloodstream across the 
postcapillary vasculature, or 3. follow 
the walls of the draining veins to reach 
the cervical lymphatics. 
 
Iliff et al. Science. 2012 
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Venous Congestion May Cause Increased 
Transcapillary Pressure & Decreased Absorbtion 
↑Venous 
Pressure 
X 
Interstitial edema 
+10mmHg -7mmHg 
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Venous Congestion & Interstitial Edema May 
Inhibit Lymphatic CSF Drainage 
X X 
X 
X 
40% of CSF drained via the 
cranial nerve lymphatics 
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CSF Production: Choroid Plexus 
Increased filtration? 
Choroid plexus in lateral, third & 
fourth ventricle produces 70-90% of 
CSF in brain 
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Hypertension Increases CSF Formation 
 Ruchoux et al. 1992 found ultrastructural changes in the choroid plexus of SHR 
reflecting increased secretory activity 
 Chronic hypertension increases choroidal blood flow 
 CSF production is directly correlated to choroid plexus blood flow 
 
 In a study of hypertension on CSF dynamics, Al-Sarraf et al: 
JVP 
(cm H2O) 
Choroidal 
Blood Flow 
(ml min-1g-1) 
CSF Secretion 
(ul ml-1) 
CSF Pressure 
(cm H2O) 
WKY 2.4 +1.1 2.41 +/- 0.08 2.61+/- 0.21 8.4 +/-2.3 
SHR 7.6 + 2.8* 2.82 +/- 0.21** 3.38 +/-0.11** 16.8 +/- 5.1* 
Al-Sarraf et al. Effect of hypertension on the integrity of the blood brain barrier and blood CSF barriers, cerebral blood flow and CSF 
secretion in the rat. Brain Research 2003; 975:179-188. 
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Increased AQP1 Expression in the  
Choroid Plexus of Hypertensive Animals 
 Tomassoni et al. Brain Research 2010 
• Stronger staining in 
the choroid plexus 
apical membrane of 6 
month  SHR vs 
normotensive controls 
• AQP1 expression 
   
  
 
Immunohistochemistry 
Normotensive Hypertensive 
Tomassoni et al. Expression of aquaporins 1 and 4 in the brain of spontaneously hypertensive rats. Brain Research 2010; 1325:155-163. 
Aquaporin 1-Membrane Protein 
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Flow analysis of CSF through the 
aqueduct 
• The flow analysis of CSF through the aqueduct (axial 
oblique section noted as dashed line --Bottom).  
• A CINE phase contrast sequence obtained 
perpendicular to the mid cerebral aqueduct showing 
velocity versus time after the QRS wave (graph --- top 
left) Case #5: 
•R+30: CSF production rate=305 ul/min 
• CSF peak velocity=3.65cm/s 
•R+57: LP opening pressure=28.5 
•R+180:CSF production rate=682 ul/min 
• CSF peak velocity=7.80cm/s 
• Cross sectional image through the mid cerebral 
aqueduct (Middle) showing the area of flow analysis 
• T1 weighted mid sagittal image (Bottom) showing 
plane of section through the mid cerebral aqueduct 
• There is no obvious narrowing of the cerebral 
aqueduct. CSF production rate is approximately one 
standard deviation above average in several cases 
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Normal CSF Diffusion Gradient 
ICP= 10mmHg 
Venous Sinus Pressure=5-
7mmHg 
Normal SSVP:CSFP= 0.60 
Therefore delta driving pressure only~3-5mmHg 
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CSF Resorption:  
Arachnoid Granulations 
Electron micrograph of outer arachnoid granulation- 
apical region- showing collagen fibers surrounding 
the pores and linking the granulations 
Electron Micrograph of clustered arachnoid granulations from the 
floor of the superior sagital sinus. Arrows pointing to lobules 
Inflammation of the arachnoid villi as 
one mechanism inhibiting resorption? 
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Blocked Lymphatic Drainage of CSF 
Perineural pathways along 
cranial nerves for 
subarachnoid CSF- 
lymphatic connections  may 
become congested 
decreasing absorbtion 
(thin curved arrows) 
Low pressure system 
ISS Inflight CO2 Levels: 
• CO2 mission average=3.56mmHg (0.33%) 
   (10x normal sea level atmospheric: 0.0314%) 
• Average Peak CO2=8.32mmHg (0.7%) (20x) 
 
ISS Commander Jeff Williams working on CDRA unit 
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Increasing PaCO2 Increases Cerebral 
Blood Flow, & Mean Arterial Pressure 
CPP=MAP-ICP 
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Intracranial Blood Volume Increases in 
Direct Proportion to Increasing PaCO2 
40 38 42 36 34 
 2 
 8 
 6 
 4 
 10 
End-tidal pCO2 mmHg 
• Greatest rate of change in ICP 
occurs between 30-50mmHg* 
PaCO2-steepest portion of curve 
*Paul RL, et al: Intracranial pressure responses to alterations in arterial carbon dioxide 
pressure in patients with head injuries. J Neurosurg 36:714–720, 1972 
 
• PaCO2 Increased 7.0mmHg, 
resulted in more than doubling of 
ICP  from 10→21mmHg 
 
 
R=0.95 
B
lo
od
 V
ol
um
e 
m
l 
Yoshihara et al. Cerebrovascular carbon dioxide reactivity assessed by intracranial pressure dynamics in severely head injured 
patients. J Neurosurg 82:386–393, 1995 
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Potential Impact of Acutely Elevated 
pCO2 on ICP 
Yoshihara et al. Cerebrovascular carbon dioxide reactivity assessed by intracranial pressure dynamics in severely head injured patients. J 
Neurosurg 82:386–393, 1995 
Greenberg JH et al: Local cerebral blood volume response to carbon dioxide in man. Circ Res 43: 324–331, 1978 
 
• Low Compliance Crewmember: 
 1mmHg PaCO2/ 2.6mmHg ICP  
 9.1mmHg ↑ ICP, 2o to CO2 
 
• High Compliance Crewmember: 
 1mmHg PaCO2/ 1.4mmHg ICP 
 4.9mmHg ↑ ICP, 2o to CO2 
 
 
ISS Lowest average CO2=3.5 mmHg 
Hypercapnia 
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Cephalad fluid Shift Exacerbates CO2 
Challenge on ISS 
12 
20 
30 
Cephalad Fluid Shift 
C02 
4mmHg 
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The Translaminar Pressure  
Gradient: A Mechanism for Papilledema 
1G 0G 
CSFp 
IOP 
Area of Interest: 
Area of Magnification 
Translaminar Pressure Gradients: 
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Translaminar Pressure Difference &  
Visual Field Defect 
ICP IOP TLP Delta 
10 15 -5 5 
25 17 +8 13 
35 17 +18 23 
Examples: 
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A Working Model: Potential Interaction of the 
CNS, Vascular, & Ocular System in the VIIP 
+VP 
+CSFP 
+OVP 
+OCSFP 
9.8m/s2 X 
Hydrostatic Drainage 
Loss of  
 
Cerebral 
Venous Blood 
Adapted from Rekate 
Brain 
+CVP 
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VIIP Pathophysiological Hypotheses:  
Vascular, CNS & Ocular 
+VP 
+CSFP 
+OVP 
+OCSFP 
4. Increased CSF 
Production: ↑Blood 
flow=↑CSF Prod= ↑ICP 
8. Δ’s AQP1 
Expression: 
inflight/postflight= ↑ICP 
5. Interstitial Edema: ↑ICP = 
↑Transcapillary 
Pressure=Interstitial Edema= 
Glymphatic blockage ↑ICP 
6. Optic Nerve Head Pressure 
Gradient: compresses axons 
causing papilledema 
3. Decreased CSF Absorption: 
Increased pressure gradient to 
CSF outflow=↑ICP 
1. A. Venous Cephalad Fluid 
Shift: Decreases Venous 
Compliance ↑CVP 
2. Cerebral Venous 
Congestion: Loss 
hydrostatic drainage = 
↑ICP 
Brain 
Interstitial Edema 
7. Venous Compression: ↑ICP 
& expanding brain compresses 
venous sinuses exacerbating 
↑ICP 
3. Ocular Venous  
Engorgement: Cerebral venous 
congestion transmitted to ocular 
venous supply acutely 
increasing IOP 2o to choroidal & 
episcleral engorgement. Trends 
down chronically? 
9.8m/s2 X 
Hydrostatic Drainage 
Loss of  
 
1. B. CSF Cephalad Fluid 
Shift: Decreases cranial CSF 
compliance=↑ICP 
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Risk of Spaceflight-Induced Intracranial 
Hypertension/Vision Alterations 
 Risk Statement 
 Given that the microgravity environment causes cephalad fluid shift 
in astronauts, there is a probability that astronauts will have 
intracranial hypertension (IHT) to some degree, and if left untreated, 
could lead to deleterious health effects. 
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Operational Relevance 
 
 Vision disturbance and potential elevated intracranial pressure 
(ICP) in spaceflight are serious health risks to the astronaut 
population. Evidence to date from short-duration and long-duration 
space flights supports a dose-response relationship. NASA is 
planning exploration missions that will involve a longer duration of 
microgravity exposure. Therefore, the likelihood and consequence 
of VIIP may be higher.  Changes to vision may impact a 
crewmember’s ability to function nominally onboard, for example: 
reading computer displays, or working with robotic arms external to 
the spacecraft. Permanent visual acuity losses may result in lifetime 
disability to various degrees. In addition, the scientific literature 
suggests that some patients with the terrestrial condition of 
idiopathic intracranial hypertension (IIH), thought to be the closest 
condition analogous to VIIP, may suffer from mild cognitive 
impairment, which would be of concern to astronaut functioning and 
well-being. 
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Gaps 
 VIIP1: We do not know the etiological mechanisms and contributing 
risk factors for ocular structural and functional changes seen in-flight 
and postflight. 
 
 VIIP3: We need a set of validated and minimally obtrusive 
diagnostic tools to measure and monitor changes in intracranial 
pressure, ocular structure, and ocular function. 
 
 VIIP12: We do not know whether ground-based analogs and/or 
models can simulate the spaceflight-associated VIIP syndrome. 
 
 VIIP13: We need to identify preventative and treatment 
countermeasures (CMs) to mitigate changes in ocular structure and 
function and intracranial pressure during spaceflight. 
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VIIP1: We do not know the etiological mechanisms and 
contributing risk factors for ocular structural and functional 
changes seen in-flight and postflight. 
 
 The rVIIP project considers the VIIP 1 knowledge gap to be its 
highest priority 
 The leading hypothesis is that the VIIP syndrome is caused by 
increased intracranial pressure resulting from a cephalad 
(headward) fluid shift resulting from microgravity exposure. 
 
 Target for closure:  
Establish the etiology of VIIP syndrome development and the 
relative contribution of its hypothesized risk factors to a level 
suitable (as determined by the RCAP) to direct and focus upcoming 
countermeasure development efforts. 
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 Data Mining – Ocular structure 
 Ocular structure, biomechanics 
 Phase I: SD-OCT Analysis 
 Mapping by VESGEN-Bed Rest 
 VIIP Data Mining 
 Venous/Arterial Compliance 
 CSF Dynamics pre/postflight 
 Venous Sinus Evaluation 
 Cerebral Vascular Autoregulation 
 Diffusion Tensor Imaging 
 Brain Gene Expression Signatures 
 CSF Production and Outflow 
 
 
 Evidence Report 
 Occ. Surveillance Data Mining 
 ISS Ocular Health 
 SD/Visual Health (MRID) 
 Fluid Shifts 
 Digital Astronaut Modelling 
 Cranio-Venous Modelling 
 
 
 
 ICP in Microgravity 
 
 
 Retinal gene expression  during uG 
 Retinal gene changes in HLS 
 1-carbon  polymorphism 
 
 
VIIP1 Tasks: Etiological Mechanisms 
and Contributing Risk Factors 
HHC 
NSBRI 
SD 
 Completed 
 Ongoing 
 To start 
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Pre-Flight Pulse Pressure
Estimation for cases with 95% CI Non-Cases Cases
Best Fit (curvilinear) for Cases; R2=.45 (including BP meds predictor), p<.01
       
(   g )
Occupational Surveillance Data Mining: 
Resting Pulse Pressure (Sitting) 
Cases per CPG vs Pulse Pressure 
(Annual Preflight Exam 4-Year Mean) 
Confirmed non-cases (Green) & unclassified (Blue) 
Not included in model, for reference only 
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Occupational Data Mining in ISS Astronauts:  
Cardiovascular Variables Correlating with CPG 
 
Cardiovascular Variable 
Significant Correlation 
Across CPG 
Classification 
R2 P value 
Biochemistry: 
LDL √ 0.43 P<0.02 
HDL - 0.22 P<0.09 
Triglycerides - - 
Hemoglobin A1c √ - P<0.01 
Fasting serum glucose √ 0.125 P<0.008 
Homocysteine √ - P<0.01 
Oral sodium intake √ 0.22 P<0.05 
Body Composition: 
Body Mass Index √ 0.41 P<0.01 
Percentage Body Fat √ 0.38 P<0.01 
Cardiac: 
Resting systolic blood pressure (pre-in-post flight) √ 0.31 P<0.0002 
Pulse Pressure (pre-in-post flight) √ 0.45 P<0.01 
CT Coronary Calcium Score - - - 
Aerobic Capacity: 
Decreased Maximal Oxygen Uptake √ - P<0.04 
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Metabolic Syndrome 
Hypertension Hyperglycemia Hypertri- glyceridemia 
Elevated LDL 
Decreased HDL 
Impaired 
Fibrinolysis 
Hyper- 
coaguability 
Oxidative Stress 
ROS 02- 
Endothelial 
Dysfunction ↓NO2 
Inflammation 
Proliferation ↑CRP 
Vascular Dysfunction 
Metabolic Syndrome-Vascular Relationship 
Decreased Compliance/Increased Susceptibility to VIIP 
Clinical Intervention 
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Platts-Venous Compliance Bed Rest 
Aims: To track changes in venous and arterial compliance in the head and 
neck vasculature due to bed rest and determine relationship to 
morphological alterations of the eye. Is bed rest an adequate model? 
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Platts-Venous Compliance Inflight 
Aims: Are venous compliance changes inflight contributing to VIIP?  
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Effects of Microgravity on Central Venous 
Pressure & Intracranial Pressure 
Ommaya reservoir 
Utilized for CNS drug delivery 
Pressure Transducer 
Measures ICP 
Right Heart Catheterization to 
measure CVP 
Measurement of ICP & CVP during 24hr tilt testing 
+/- Braslet, +/- CO2 with ocular ultrasound 
PI: Dr. Ben Levine:  
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Ommaya reservoir 
Utilized for CNS drug delivery 
Pressure Transducer 
Measures ICP 
Right Heart Catheterization to 
measure CVP 
Measurement of ICP & CVP during parabolic flight  
and with CO2, and strength challenge 
 
Effects of Microgravity on Central Venous 
Pressure & Intracranial Pressure 
How do alterations in CVP in uG impact ICP?  
Page No. 77 
 Data Mining – Ocular structure 
 Ocular structure, biomechanics 
 Phase I: SD-OCT Analysis 
 Mapping by VESGEN-Bed Rest 
 VIIP Data Mining 
 Venous/Arterial Compliance 
 CSF Dynamics pre/postflight 
 Venous Sinus Evaluation 
 Cerebral Vascular Autoregulation 
 Diffusion Tensor Imaging 
 Brain Gene Expression Signatures 
 CSF Production and Outflow 
 
 
 Evidence Report 
 Occ. Surveillance Data Mining 
 ISS Ocular Health 
 SD/Visual Health (MRID) 
 Fluid Shifts 
 Digital Astronaut Modelling 
 Cranio-Venous Modelling 
 
 
 
 ICP in Microgravity 
 
 
 Retinal gene expression  during uG 
 Retinal gene changes in HLS 
 1-carbon  polymorphism 
 
 
VIIP1 Tasks: Etiological Mechanisms 
and Contributing Risk Factors 
HHC 
NSBRI 
SD 
 Completed 
 Ongoing 
 To start 
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Pre and Postflight Measurement of 
Cerebrospinal Fluid (CSF) Dynamics & ICP  
 
 PI: Noam Alperin, Ph.D. 
 Aims: Retrospective study will evaluate pre and postflight MRI data from 
long-duration crew members to determine cerebrospinal fluid (CSF) 
dynamics & ICP, to identify changes due to space flight. 
 Clinical Applications:  
• Non-invasive ICP measurement- diagnosis & treatment 
• Non-invasive craniospinal compliance –susceptibility 
 
 Is ICP altered in ISS crew following flight? 
 
 
3D plot of the blood flow velocities: right carotid  
artery, vertebral artery and jugular vein. 
Velocity encoded MRI images of CSF flow(b) used for 
derivation of the blood CSF volumetric flow rate waveforms 
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Pre & Postflight MRV Review (Central 
Venous Congestion/Stenosis) 
 
 PI: Riascos-Casteneda 
 Aims: Evaluate central venous congestion and stenosis in astronauts pre 
and postflight.  
 
 Clinical Applications:  
• Determination of whether or not astronauts present with signs of 
cerebral venous compression following flight 
 
 Is venous compression secondary to elevated ICP present  in crew 
following flight? 
 
Focal narrowing in right & left transverse sinus 
in Idiopathic Intracranial Hypertension 
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P=0.004 P=0.014 
Percent Change (Diameter) in Dominant Regions + Dsag 
by Flight Duration 
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Cephalad Fluid Redistribution  
PI: Donna Roberts 
 Specific Aim #1: Characterize weightlessness-induced intracranial compartmental fluid 
volume changes. 
 Specific Aim #1a (Macroscopic Fluid Volume Changes):  Perform a volumetric analysis 
of the brain and CSF to assess for any potential shifts in brain and intracranial CSF 
volume induced by microgravity exposure.   
 Specific Aim #1b (Arterial and Venous Fluid Volume Changes): Perform volumetric 
analysis of the regional arterial cerebral blood volume and venous outflow to assess for 
evidence of cerebral venous insufficiency  
 Specific Aim #2: Evaluate the impact that exposure to microgravity has on human 
cerebral hemodynamics including cerebral perfusion. 
 Do volume changes and compartment volume shifts occur in the brain following flight? 
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Brain Gene Expression Signatures 
 PI: Zanello 
 Aims: Sample CSF in IIH patients to examine neuronal cell RNA exosomes 
to determine if white matter disease genetic changes are present? 
 Does  chronically elevated ICP damage neuronal cells and predispose to 
white matter disease? 
Neuronal Cell 
CSF Space 
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CSF Production: Choroid Plexus 
Choroid plexus in lateral, third & fourth ventricle produces 70-90% of CSF in brain 
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Is CSF production altered as a consequence of cephalad fluid shift? 
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CSF Resorbtion: Arachnoid Granulations 
P1 
P2 
P2 
P1 
Is CSF resorbtion altered as a consequence of cephalad fluid shift? 
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 Data Mining – Ocular structure 
 Ocular structure, biomechanics 
 Phase I: SD-OCT Analysis 
 VIIP Data Mining 
 Venous/Arterial Compliance 
 CSF Dynamics pre/postflight 
 Venous Sinus Evaluation 
 Cerebral Vascular Autoregulation 
 Diffusion Tensor Imaging 
 Brain Gene Expression Signatures 
 CSF Production and Outflow 
 
 
 Evidence Report 
 Occ. Surveillance Data Mining 
 ISS Ocular Health 
 SD/Visual Health (MRID) 
 Fluid Shifts 
 Digital Astronaut Modelling 
 Cranio-Venous Modelling 
 
 
 
 ICP in Microgravity 
 
 
 Retinal gene expression  during uG 
 Retinal gene changes in HLS 
 1-carbon  polymorphism 
 
 
VIIP1 Tasks: Etiological Mechanisms 
and Contributing Risk Factors 
HHC 
NSBRI 
SD 
 Completed 
 Ongoing 
 To start 
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Astronaut Data Mining: Ocular Structure, 
Retrospective 
Gap: VIIP 1 (Etiology/Risk Factors) 
Timeframe: FY14 
 
Aim: Evaluate the changes in ocular 
structure and biomechanics during space 
flight, such as crowded disc, posterior 
eye radius, degree of refraction, 
intraocular pressure (IOP), corneal 
thickness, retinal pigmented epithelial 
angle (RPE), and translaminar pressure 
gradient.  
 Do biomechanical factors of the eye 
predispose certain crew to developing 
VIIP? 
 
 
Input factors in Modeling Strain on the ONH 
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Ocular Structure - Flight 
Gap: VIIP 1 (Etiology/Risk Factors) 
Funding Status: Not funded 
 
 Aim: This prospective flight study will examine pre- and postflight 
measures of ocular structure and biomechanics (e.g. crowded disk, 
scleral thickness, optic canal opening, posterior eye radius, degree 
of myopia, intraocular pressure (IOP), corneal thickness, retinal 
pigmented epithelial angle (RPE), and translaminar pressure 
gradient). The task will contribute to gap closure by characterizing 
any pre/postflight changes in ocular structure and correlating these 
measures to the incidence and magnitude of symptoms of the VIIP 
syndrome. 
 *This work is a follow-up to the task “Ocular Structure Data Mining.” 
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SD OCT Data mining 
 PI: N. Patel 
 Aim: Are OCT changes of the optic nerve head  present in ISS crew 
following flight? 
 Do changes in retrobulbar 
 optic nerve CSF pressure and 
 blood flow precipitate optic nerve  
head alterations? 
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SD OCT Data mining 
Positive relationship 
between scleral opening 
and RNFL thickness  
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 Data Mining – Ocular structure 
 Ocular structure, biomechanics 
 Phase I: SD-OCT Analysis 
 Mapping by VESGEN-Bed Rest 
 VIIP Data Mining 
 Venous/Arterial Compliance 
 CSF Dynamics pre/postflight 
 Venous Sinus Evaluation 
 Cerebral Vascular Autoregulation 
 Diffusion Tensor Imaging 
 Brain Gene Expression Signatures 
 CSF Production and Outflow 
 
 
 Evidence Report 
 Occ. Surveillance Data Mining 
 ISS Ocular Health 
 SD/Visual Health (MRID) 
 Fluid Shifts 
 Digital Astronaut Modelling 
 Cranio-Venous Modelling 
 
 
 
 ICP in Microgravity 
 
 
 Retinal gene expression  during uG 
 Retinal gene changes in HLS 
 1-carbon  polymorphism 
 
 
VIIP1 Tasks: Etiological Mechanisms 
and Contributing Risk Factors 
HHC 
NSBRI 
SD 
 Completed 
 Ongoing 
 To start 
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Spaceflight Effects on the Mouse Retina: 
Histological, Gene Expression and Epigenetic 
Changes After Flight on STS-135 
 
 PI: S. Zanello 
 Aims: Perform histological and gene expression analysis of retinas 
collected from C57BL/6 mice flown in STS-135 (and from ground 
control counterparts). Histological and gene expression outcomes 
focused on cellular stress, oxidative stress, DNA damage and 
cellular death and survival. 
 Results : 
• Histological analysis for apoptosis: 30 % more apoptotic activity 
in FLT vs Ground Controls  
• DNA damage caused by oxidative stress, was elevated in flight 
samples for the retinal ganglion cells and inner nuclear layer 
 Hypoxic stress is occuring at the optic nerve head in uG?√ 
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Hindlimb Suspension (HS) as an Analog Model 
of Ocular Alterations Associated with Cephalad 
Fluid Shifts: Resveratrol as a Countermeasure  
  PI: S. Zanello 
 Aims: Testing the hypothesis that cephalad fluid shift represents a stress factor 
that induces optic disc neuroanatomical changes, as well as retinal cell 
deterioration and loss via oxidative stress.  
 Results: First evidence of molecular changes (gene expression) in the 
retina due to hindlimb suspension 
1. Egr1 (early growth response protein-1) a transcription factor 
responsive to mechanical stress, is induced in the retina due to HS. 
Egr1 induction by HS is reversed by recovery in normal posture after 
HS and suppressed by antioxidant-rich diet with green tea extract. 
2. Shown that resveratrol diet-fed animals had thicker retinas compared 
to animals fed on a control diet in HS 
 
 Cephalad fluid shift may be causing ocular changes as demonstrated 
by mechanical changes and oxidative stress 
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Evaluation of the Role of Polymorphism of Enzymes 
Involved in 1-Carbon Metabolism on the VIIP Risk 
 
 PI: S. Smith 
 Aims: Evaluation of the Role of Polymorphism of Enzymes involved in 1-
carbon Metabolism  
 Elevations in 4 metabolites of the one-carbon metabolism pathway have 
been identified in 7 affected crew members studied to date. These 
elevations and related data suggest that polymorphism(s) of one or more of 
the enzymes in this pathway exist(s) in affected crew members.  
 Does a genetic error of metabolism contribute to VIIP? 
 
Zwart et al. Journal of Nutrition. Feb 2012. 
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 Data Mining – Ocular structure 
 Ocular structure, biomechanics 
 Phase I: SD-OCT Analysis 
 Mapping by VESGEN-Bed Rest 
 VIIP Data Mining 
 Venous/Arterial Compliance 
 CSF Dynamics pre/postflight 
 Venous Sinus Evaluation 
 Cerebral Vascular Autoregulation 
 Diffusion Tensor Imaging 
 Brain Gene Expression Signatures 
 CSF Production and Outflow 
 
 
 Evidence Report 
 Occ. Surveillance Data Mining 
 ISS Ocular Health 
 SD/Visual Health (MRID) 
 Fluid Shifts 
 Digital Astronaut Modelling 
 Cranio-Venous Modelling 
 
 
 
 ICP in Microgravity 
 
 
 Retinal gene expression  during uG 
 Retinal gene changes in HLS 
 1-carbon  polymorphism 
 
 
VIIP1 Tasks: Etiological Mechanisms 
and Contributing Risk Factors 
HHC 
NSBRI 
SD 
 Completed 
 Ongoing 
 To start 
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 VIIP Evidence 
book published 
June 18, 2012 
 IOM Review Dec. 
19, 2013 
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Post-flight Exams 
R+1-3 R+30 R+180 R+90 R+365 
Victory Lakes 
MRI  
Pre-flight Exams 
L-21/18 mo L-12-3 mo 
Victory Lakes 
MRI  
Bldg. 261: 
•Cardiac  Ultrasnd 
•Blood Pressure  
Ocular Ultrasound at L-
12/9 and 6/3 mo;  
All other tests at L-9/6 mo 
Flt Med. Clinic  
 
•Vision Testing* 
•Fundoscopy 
•Refraction 
•Pupil Reflexes 
•Extra-Ocular 
Muscle Bal. 
•IOP (Tonometry) 
Coastal Eye 
Assoc: 
•OCT/A-Scan 
•Biomicroscopy/ 
Hi Res Photogr. 
•Blood pressure  
for IOP  
In-flight Exams 
L+10 L+90 L+30 L+60 L+120 R-30 
MedB allows the addition of a session without 
research components at L+100 if requested & 
as clinically indicated 
•Ocular Ultrasnd 
•Fundoscopy 
•IOP (Tonometry) 
 
 
 
•Vision Testing* 
•Blood pressure  
for IOP  
•Cardiac  Ultrasnd 
•Blood Pressure  
Flt Med. Clinic  
•Ocular Ultrasnd 
•Vision Testing* 
•Fundoscopy 
•Refraction 
•Pupil Reflexes 
•Extra-Ocular 
Muscle Bal. 
•IOP (Tonometry) 
Coastal Eye 
Assoc: 
•OCT/A-Scan 
•Biomicroscopy/ 
Hi Res Photogr. 
•Blood pressure  
for IOP  
Bldg. 261: 
•Cardiac  Ultrasnd 
•Blood Pressure  
Flt Med. Clinic  
•Ocular Ultrasnd 
•Vision Testing* 
•Fundoscopy 
•Refraction 
•Pupil Reflexes 
•Extra-Ocular 
Muscle Bal. 
•IOP (Tonometry) 
Coastal Eye 
Assoc: 
•OCT/A-Scan 
•Biomicroscopy/ 
Hi Res Photogr. 
•Blood pressure  
for IOP  
                         
      
ISS Ocular Study 
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Ocular Health Study Aims & Rationale: 
 PI: C. Otto 
1. Increased frequency of crew VIIP testing is required to: 
a) Define the temporal sequence for the appearance of signs and 
symptoms. 
b) Delineate the interaction between duration of weightlessness and 
severity of symptoms, i.e. the dose-response. 
c) Identify whether VIIP signs and symptoms recover post-flight and 
determine the impact of prolonged changes on crew health. 
 
 Outline physiological systems relationships in VIIP , and aid in 
guiding development of countermeasures and targeted treatments.  
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Fluid Shifts Specific Aims 
 PI’s: M. Stenger, A. Hargens & S. Dulchavsky 
 Specific Aim I: To characterize fluid distribution and 
compartmentalization before, during and after long-duration space 
flight.   
 Specific Aim II: To correlate in-flight alterations of eye structure, ocular 
vascular parameters, and vision with headward fluid shifts, vascular 
dimensions and flow patterns. 
 Specific Aim III: To determine systemic and ocular factors of individual 
susceptibility to the development of ICP elevation and/or vision 
alterations. 
 Outline the interaction of physiological systems in VIIP , and aid in 
guiding development of countermeasures and targeted treatments.  
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Fluid Shifts Before, During and After Prolonged 
Space Flight : Associations with ICP and Visual 
Impairment 
 
C
EPH
ALA
D
 FLU
ID
 SH
IFT 
• PIs: Stenger, Dulchavsky & Hargens 
• Total body water, extracellular and intracellular fluid volume will be 
determined by biochemical dilution techniques  using Deuterium oxide 
and bromide ingestion 
• Pre & postflight to include tilt table testing 
• Ultrasound to assess upper/lower body  interstitial fluid & vein 
diameter changes 
• Ocular ultrasound & IOP measured 
 
 
Page No. 100 
Fluid Shifts Before, During and After Prolonged 
Space Flight : Associations with ICP and Visual 
Impairment 
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Chibis-M 
Tonometry 
Fundoscopy 
Ocular Ultrasound 
Echocardiography 
Fluid Shifts with In-Flight 
Chibis-M 
+ICP 
Measurement  
with CCFP 
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Role of the cranial venous circulation in  
microgravity-associated visual changes 
 PI: J. Buckey 
 Problem- Cranial venous circulation may be important in 
microgravity-induced visual changes, but the interaction 
between fluid shifts and hydrostatic pressure changes in the 
circulation is complex. 
 Overall Goal- Develop a numerical model of the cerebral 
venous circulation to provide an integrated understanding of 
the changes 
• Aim I – Develop numerical model 
 Incorporates circulatory system, CSF system, and eye  
• Aim II – Measure cranial venous changes during fluid shifts and 
hydrostatic pressure changes to validate the numerical model 
 Use MRI to measure cranial venous anatomy, compliance and flows during shifts 
• Aim III – Identify critical venous variants involved in maladaptation to 
fluid shifts 
 ID susceptible variants in Aim II and further study 
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 CO2 Data mining headaches  
 CO2 Data mining Vision  
 
 Are Medications Involved in Vision and 
Intracranial Pressure Changes Seen in 
Spaceflight? 
 Assessment of bedrest, CO2, Resistive 
Exercise & High Sodium (Envihab) 
 
 
VIIP1: Etiological Mechanisms and 
Contributing Risk Factors 
Environmental/Occupational 
 ICP in Microgravity & resistive 
exercise 
HHC 
NSBRI 
SD 
 Effects of gamma radiation  
      on the retina 
 
 Completed 
 Ongoing 
 To start 
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Limit Resistive Training: 
Resistive Exercise 
Does in-flight resistance 
training cause additional 
transient elevations in 
ICP? 
60 
Resistive Exercise Repetitions causing 
spikes in ICP 
(1 hour x 5 sessions per week) 
Max 2-Leg Press with Valsalva  CVP↑ 56mmHg 
Max 2-Leg Press no Valsalva  CVP↑ 9mmHg 
Pott et al. J Applied Physiol. 2003 
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CO2 (mmHg) 
Predicted Probability of Headache 
Associated with 24 Hour Average CO2: Expeditions 2-31 
Predicted
95% Confidence Limits
24 Hour CO2 
average calculated 
based on the date 
of the report of 
headache (PMC or 
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 CO2 associated with Headache 
and possibly increased ICP 
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Are Medications Involved in Vision and Intracranial 
Pressure Changes Seen in Spaceflight? 
 
 PI: V. Wotring  
 Aims: Determine if affected crewmembers use medications known to 
be associated with cardiovascular, visual changes and ICP elevations 
in terrestrial medical practice and to assess the likelihood of 
medications as causal agents in spaceflight-associated visual 
changes and ICP elevation. 38 medications in the ISS kit have the 
potential to affect BP/ICP/IOP  (~ 35% of kit).  
 Clinical Applications: Treatment 
• Avoidance of exacerbating medications, symptom reduction 
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Effects of Gamma Irradiation (alone or combined with 
dietary iron overload) on the rat retina  -  (PI: S.Zanello- 
tissue sharing with S. Zwart) 
Oxidative stress-induced DNA 
damage (measured as 8OHdG 
immunoreactivity on retina 
histologic sections (note the 
increase in 8OHdG density units 
for radiation compared to 
control). Similar results were 
observed on other cell layers of 
the retina 
(8-hydroxydeoxygaunasine (guanasine oxidative stress ) 
Page No. 109 
Envihab-Bedrest 
 HDT Bedrest, CO2, resistive exercise, 
Sodium loading, & ICP measurement 
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 SD/Upgrade Visual Acuity Software  
      & In-flight Tonometer 
 SD/Fundoscopy Trade Study 
 SD/Development of In-Flight Fundoscopy 
 SD/Diagnostic OCT Trade Study 
 SD/Development in-flight diagnostic OCT 
 Retinal Vascular Remodeling/VESGEN 
 
 Pilot-Non-invasive CVP Device 
 Non-invasive ICP evaluation-Vittamed  
 CCFP Clinical Database   
 Comparison of Continuous Non-
Invasive  & Invasive ICP 
 ICP Tech Search 
 Validation of in-flight non-invasive ICP  
with LP 
 
 
VIIP3: Minimally Obtrusive Diagnostic Tools 
for Measurement and Monitoring 
 Volumetric Ophthalmic 
Ultrasound 
 
HHC 
NSBRI 
SD 
 Completed 
 Ongoing 
 To start 
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Pilot study to Evaluate a Novel Non-Invasive 
Technology to Measure Central & Peripheral 
Venous Pressure 
 
 PI: David Martin 
 To confirm the relation between compression sonography as a non-
invasive measure of peripheral venous pressure and CVP. Central 
venous pressure is one of the primary factors which have been 
hypothesized to contribute to the development of elevated ICPin 
astronauts during and after space flight.  
 Clinical Application: Diagnosis 
• Measurement of CVP 
(A) Pressure manometer connected to 
ultrasound transducer:  
(1) translucent silicone membrane,  
(2) ultrasound transducer,  
(3) flexible pressure tubing,  
(4) pressure meter.  
 
(B) Cross-sectional sonography: cephalic 
vein before and after compression. 
Thalhammer et al. Noninvasive CVP Measurement. 
(A) Linear regression: positive correlation between PVPi and PVPn. 
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Non-invasive ICP Device Purchase & 
Evaluation 
 
 PI:  Eric Bershad 
 Aims: Evaluation and validation of the Vittamed non-invasive, 
absolute intracranial pressure measurement device 
 Clinical Applications: Diagnosis & Treatment 
• Non-invasive measurement of ICP 
Page No. 113 
Tympanic Membrane Displacement (TMD) 
 Cerebral and Cochlear Fluid Pressure device 
(CCFP) 
 
How it works: 
 Cochlear aqueduct connects perilymphatic space 
to subarachnoid space 
 ↑ ICP distributes force to perilymph in cochlea 
• Affects resting position of Stapes via oval window 
• Alters the position of the tympanic membrane 
 Measures the direction and volume in nanoliters 
of the tympanic membrane displacement in one 
of 2 modes: 
• Spontaneous (tympanic movement in response to 
cardiac/respiratory pulsations)  
• Elicited (in response to high intensity sound (~100 
dB) which elicits the Stapedial reflex 
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1. SD/Fundoscopy Trade Study  
2. SD/Development of In-Flight Fundoscopy 
 
 
 
 The NASA Space Medicine group performed a trade study to identify 
the optimal fundoscopy device for both clinical and research use 
during flight.   
 Deliverables: A fundoscopy device that can be developed into 
hardware for use during flight. In February 2012, HMS Hardware Team 
selected the MERGE EyeScan. Flight ready fundoscopy hardware. 
 Clinical Applications: Diagnosis 
• High resolution digital imaging of the fundus 
 
NASA Astronaut Karen Nyberg 
Self-exam with Merge Eyescan fundoscope 
Expedition 36 
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Preflight                   Postflight 
Inferior            Superior      Inferior    
                   Superior 
  
1. SD/Diagnostic OCT Trade Study 
2. SD/Development of in-flight diagnostic OCT 
 
  The NASA Space Medicine group performed a trade study to identify 
the optimal optical coherence tomography (OCT) device  
• Heidleberg Spectralis with Eye tracking laser tomography 
 The modified flight unit was delivered to ISS onboard the ESA Albert 
Einstein ATV that docked June 15. 
 Clinical Applications: Diagnosis, Treatment 
• Early identification of choroidal and RNFL swelling 
• Early intervention, and treatment monitoring 
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 Optic Nerve/Sheath  
      Remodeling Simulator 
 Rodent HLS (Fuller/Zanello) 
 Rodent HLS (Zanello) 
 GRC/Digital Astronaut: VIIP modeling 
 JSC/Digital Astronaut: VIIP modeling 
 Cranial Venous Circulation in uG 
 bedrest plus CO2, Resistive Exercise & 
      High Sodium 
 
 
  
VIIP12: Ground-based Analogs & Models 
HHC 
NSBRI 
SD 
 Completed 
 Ongoing 
 To start 
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• Cohort 1 
• 33 Young adult male rats 
• 33 Controls 
 90 day HLS= 2.5 Year Mission 
 Male & female 
 Young and old 
 CO2 challenge (1%) 
 Telemetry: Instrumented rodents 
• Continuous ICP monitoring 
• IOP 
 MRI Pre/In/post (30,60,90d) 
 OCT Pre/In/post (7,14,28,90d) 
 Histology 
 Post suspension recovery time 
 Controls: No suspension 
• Cohort 5 
• 33 Middle age male rats, 
1% CO2 
• 33 Controls 
• Cohort 2 
• 33 Middle age male rats 
• 33 Controls 
• Cohort 3 
• 33 Young female rats 
• 33 Controls 
Head-Down Tilt in Rats: A Model for Intracranial & 
Intraocular Pressures, & Retinal Changes During 
Spaceflight  
 
PI: C. Fuller / S. Zanello 
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Head-Down Tilt in Rats: A Model for Intracranial & 
Intraocular Pressures, & Retinal Changes During 
Spaceflight  
 
 Deliverables: A validated rodent analog and the influence of gender, 
age, CO2 on ICP and IOP in the VIIP syndrome 
 Clinical Applications: Knowledge, Diagnosis & Treatment 
• Interaction of ICP:IOP and TLPG on the retina 
• Influence of CO2 on ICP:IOP 
• Aquaporin expression & CSF production in the choroid plexus 
• Arachnoid Granulation function & resporbtion of CSF 
 
Retinal Histopathology Retinal Gene Expression Analysis 
VESGEN 
Vascular Remodelling 
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 Raise IOP (Ibopamine) 
 Aerobic Exercise 
 Mechanical:  
 Braslet 
 Abdominal LBNP 
Drug: 
 Venous Capacitance Augmentation 
 Afterload reduction (ACEI) 
 
 ICP Drug Countermeasure 
(Acetazolamide, ANP, AQP1/4 antagonist) 
 
 
 Fluid Shifts 
 CM Flight Validation  
      (combination CM) 
 Fluid Shifts “2” 
 NSBRI/Envihab Bedrest VIIP CM 
 
 
 
 
VIIP13: Preventative and Treatment 
Countermeasures 
HHC 
NSBRI 
SD 
 Completed 
 Ongoing 
 To start 
 Inflight CO2 Reduction 
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No Braslet Braslet 
IJ Vein IJ Vein 
Duncan et al. NASA SDTO 17011  
Leg 
Neck 
Leg 
Neck 
Sequesters venous blood in the legs 
U.S. - Russian ISS In-flight Braslet  
Occlusion Cuff Study  
Hamilton et al. Cardiac and vascular responses to thigh cuffs and respiratory maneuvers on crewmembers of the International Space Station.  
 J Appl Physiol 112: 454–462, 2012 
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uG Measures 
% 1G Baseline 
Braslet Off Braslet On 
Femoral Vein  
X-section 0.58 cm
2 1.02 cm2 * 
Internal Jugular 
Vein X-section 1.23 cm
2 0.95 cm2 
Left Ventricular 
Stroke Volume 69.3cm
3 60.7cm3* 
Cardiac Output 4.18 L/min 3.37 L/min* 
 
 
U.S. - Russian ISS In-flight Braslet  
Occlusion Cuff Study  
•   14 sessions on 9 ISS crew members 
•   Average exposure to uG at time of measurements=122 days 
 
Duncan et al. NASA SDTO 17011  
* Significant Difference 
Once Braslet is applied responses trend more similarly to terrestrial values 
Braslet and impact on ICP? (Likely lowers) 
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CO2 Levels on ISS: 7-Day 
 Note: CO2 level for time period of SMOT Notes 
 Since CO2 Reduction CHIT instituted, incidence of papilledema among ISS crew has dropped  
      from 25% to 18% 
 Is CO2 a significant contributor to VIIP? 
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 THE VISUAL IMPAIRMENT INTRACRANIAL 
PRESSURE RISK IN LONG DURATION U.S. 
ASTRONAUTS: EPIDEMIOLOGY AND 
PATHOPHYSIOLOGY 
 
Christian Otto, M.D., M.MSc. 
Lead Scientist, NASA VIIP Risk 
Yael Barr, M.D., MPH 
Deputy Scientist, NASA VIIP Risk 
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Correlation of ONSD & Visual Field Deficit 
 T. Salgarello et al. Optic nerve diameters and perimetric thresholds in idiopathic 
intracranial hypertension. British Journal of Ophthalmology 1996;80:509-514 
 20 patients with IIH (mean age=47) papilledema grade 1.1(range 0-4), 20 controls 
 CSF pressure=260-320mmH2O, Mean duration disease=7.65 years 
 Perimetric defects in 70% of eyes (28/40) 
 Deficit associated with papilledema grade 
MD: Average deviation from age matched 
controls 
PSD: Measure of visual field irregularities 
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Blind Spot Enlargement Following Papilledema 
Regained normal 
disc appearance 
Chronic Disc Changes 
Papilledema grade Δ 2.25 to 0.9 
Papilledema grade Δ 
1.9 to 0 
Normal Blind Spot Area 
 Sorenson et al. Clinical course and prognosis of 
pseudotumor cerebri. A prospective study of 24 
patients. Acto Neurol Scand., 1988:77:164-172 
 24 IIH patients, symptoms present 1-30 
months 
 Median CSFp=25mm Hg (range 8-45), all had 
papiledema initially 
 Followed for 49 months, treated with Diamox 
and diuretics 6-18 months 
 Patients who regained normal disc (50%) had 
shorter duration of disease (median=4 months) 
vs those who developed chronic changes 
(median=12months) 
 Visual field testing not conducted 
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Visual Loss Associated with Papilledema Grade 
 M.Wall. Asymmetric Papilledema in Idiopathic Intracranial Hypertension: Prospective 
Interocular Comparison of Sensory Visual Function. IOVS, Jan.1998, Vol. 39, No. 1 
 9 IIH patients (mean age=31.8) with asymmetric papilledema 2+ grade diff.  
• High grade=3 (2-5) vs Low grade=1 (0-2) 
 Mean CSFp=347.2 mm H2O 
 Visual loss most prominent in eye with higher grade papilledema 
 High grade papilledema should be regarded as a risk factor for visual loss 
Depression of the visual island with 
increasing papilledema grade 
The Visual Island 
Normal 
Low Grade Papill. 
High Grade Papill. 
Profile Perimetry 
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Mild Papilledema and Visual Field Loss 
 G. Rebolleda et al. Follow-up of Mild Papilledema in 
Idiopathic Intracranial  Hypertension with Optical 
Coherence Tomography. IOVS. 2009 Vol 50, No 11 
 N=22, mean age=40, recent diagnosis of IIH 
 Mild papilledema, mean= Frisen 2 (range 1-3) 
 Mean CSFp=35cmH2O (range 25.5-45) 
 1 Year follow-up: 
• Perimetry: 66% normal VF, 18% enlargement blind 
spot, 16% irreversible field loss 
• OCT: 10 RNFL thinner than normal (3 visual field 
constriction, 3 inferonasal defects, 1 had a scotoma) 
 RNFL swelling and attrition may occur simultaneously 
 Perimetry needed with OCT, since OCT cannot 
distinguish between decreased swelling vs axonal loss 
 Both OCT and perimetry required for F/U 
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Visual Field Damage Following Regression of 
Papilledema 
 R. Laemmer. Detection of nerve fiber atrophy in apparently 
effectively treated papilledema in idiopathic intracranial 
hypertension. Graefes Arch Clin Exp Ophthalmol (2010) 
248:1787–1793 
 23 IIH patients, mean age 33.8, 23 controls 
 Mean follow-up in patients with regression of 
papilledema=27 months 
 8/13 (63%) regressive papilledema group had 
mild-moderate concentric visual field damage-
superior and inferior regions 
 Patients with papilledema, only 1/10 
detectable visual field loss 
 Data show significant reduction RNFL as a 
sign of axon loss in patients with apparently 
treated papilledema 
 Minor loss of axons will be masked by 
structure of retina, with overlapping receptive 
fields. Thus, 40% of RNFL may be lost before 
occurrence of visual field damage 
Mild Severe Normal 
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Increased Volume=Increased Pressure 
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Ocular Venous Hypertension via Optic  
Nerve Compression 
A. Normal distal optic nerve/sheath complex & 
head in longitudinal cross section 
B. Papilledema showing enlargement of subarachnoid 
space & compression central retinal vein (CV) 
Increasing ICP transmitted to optic         
nerve via CSF space causes 
compression of optic nerve  
 
Axoplasmic flow inhibited resulting in 
papilledema-swelling and protrusion of 
the optic nerve head 
 
V-vitreous 
D-Disc 
Sc-sclera 
C-Choroid 
A-Arachnoid space 
S-Optic nerve sheath 
N-Optic Nerve 
CV-Central retinal vein 
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Measurement of the RPE Angle 
 
•   Angle formed between a line drawn tangential to the curve of the unaltered RPE/BM in   
the peripapillary retina furthest from the optic nerve head & the altered border adjacent to 
the neural canal opening  
 
•   Direction of the RPE/BM angle measured with the image centered on the center of the 
optic disc 
 
•   The relative RPE/BM angulation inward, towards the vitreous, measured as  positive & 
outward as negative. For each eye, angulation was considered positive if > 5 degrees 
inward angulation. Considered negative if < or equal to 5 degrees. Neutral if between the 
two. 
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RPE Angle Results 
 Positive angulation of the RPE/BM borders 20/30 eyes (67%) Mean inward 
RPE/BM angle was +1.5 degrees temporally and +2.5 degrees nasally. 
 Patients with papilledema: angulation changed with alterations in the RNFL 
thickness. For all 30 papilledema eyes, the amount of change in the nasal 
RPE/BM angle (Spearman r = 0.63, p = 0.01) correlated with the change in 
average RNFL 
 
 
 
 
 
 
 
 Papilledema with intracranial hypertension results in an inward bowing of the 
RPE/BM layer at the NCO 
 Reflects deformation of the underlying peripapillary sclera and lamina cribosa in 
response to an elevated pressure gradient [globe flattening] 
 The degree of structural stiffness can vary among patients, & influences the 
deformation of the optic nerve. Thus, two patients may respond differently to 
same CSPp 
